For most people, a cataract diagnosis once meant accepting blurry, faded vision as an inevitable part of aging. But at Frantz EyeCare, that story is being rewritten, one patient at a time, thanks to a ...

FDA IND clearance enables a phase 3 program evaluating TRIESENCE for postoperative ocular inflammation and pain following cataract surgery, aiming to broaden on-label use beyond current intraocular ...

US News evaluated freestanding ASCs only, excluding hospital-affiliated outpatient departments to avoid overlap with hospital rankings and maintain comparability across facility types. Methodology ...

Alcon and Lensar terminate merger due to FTC challenges. Lensar retains a $10M deposit and focuses on Ally laser growth. More updates on March 31.

Aurion Biotech today named Dr. Marjan Farid, Director of Cornea, Cataract, and Refractive Surgery and a Clinical Professor at ...

One medtech analyst raises concerns that Lensar's acquisition by Alcon is in trouble due to the company's recent priority ...

Johnson & Johnson (NYSE:JNJ) received FDA approval for its TECNIS PureSee IOL, an extended depth of focus intraocular lens ...

NEW YORK, March 11, 2026 /PRNewswire/ -- HelpMeSee, a global nonprofit organization dedicated to eliminating preventable cataract blindness, is featured in Healthier Together, a branded content series ...

In a healthcare landscape that continues to evolve, she acknowledges that many families may value the reassurance of a ...

Harrow, Inc. is rapidly evolving into a dominant US ophthalmic pharma player, with a 30-fold revenue increase since 2015 and ...

Lensar today entered into a priority credit line agreement in a move that analysts say casts doubt over its planned acquisition by Alcon.

Join Dr. Samy and his head technician Sidney for an informative interview all about cataracts Dr. Samy an experienced ophthalmologist and cataract surgeon explains what cataracts are how they affect ...